CorMedix Inc. (CRMD) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $568 million, CorMedix Inc. is a small-cap company. The stock currently trades at $7.21, up 1.12% today, with a 52-week range of $5.60–$17.43. The company trades at a trailing P/E of 3.2x and a forward P/E of 5.7x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.30 | $-0.30 | +67.0% | |
| 2023 | $-0.91 | $-0.91 | -23.0% | |
| 2022 | $-0.74 | $-0.74 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-25 | 0001013762-25-001852 | SEC ↗ |
| 2023-12-31 | 2024-03-12 | 0001213900-24-021585 | SEC ↗ |
| 2022-12-31 | 2023-03-30 | 0001213900-23-024310 | SEC ↗ |
| 2021-12-31 | 2022-03-29 | 0001213900-22-015852 | SEC ↗ |
| 2020-12-31 | 2021-03-30 | 0001213900-21-018684 | SEC ↗ |
| 2019-12-31 | 2020-03-16 | 0001213900-20-006521 | SEC ↗ |
| 2018-12-31 | 2019-03-14 | 0001654954-19-002741 | SEC ↗ |
| 2017-12-31 | 2018-03-19 | 0001654954-18-002777 | SEC ↗ |
| 2016-12-31 | 2017-03-16 | 0001654954-17-002094 | SEC ↗ |
| 2015-12-31 | 2016-03-15 | 0001354488-16-006585 | SEC ↗ |
| 2014-12-31 | 2015-03-12 | 0001354488-15-001120 | SEC ↗ |
| 2013-12-31 | 2014-03-31 | 0001354488-14-001544 | SEC ↗ |
| 2012-12-31 | 2013-03-27 | 0001144204-13-017913 | SEC ↗ |
| 2011-12-31 | 2012-03-19 | 0001144204-12-015866 | SEC ↗ |